$UUU
UNIVERSAL SECURITY INSTRUMENTS INC

2023 Q1 Form 10-Q Financial Statement

#000141057823000138 Filed on February 16, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4
Revenue $5.928M $5.759M
YoY Change 38.16% 8.27%
Cost Of Revenue $4.259M $4.060M
YoY Change 51.6% 12.71%
Gross Profit $1.669M $1.698M
YoY Change 12.66% -1.07%
Gross Profit Margin 28.15% 29.49%
Selling, General & Admin $1.224M $1.179M
YoY Change -16.41% -24.92%
% of Gross Profit 73.36% 69.4%
Research & Development $108.5K $101.7K
YoY Change -23.95% 4.42%
% of Gross Profit 6.5% 5.99%
Depreciation & Amortization -$3.160K $4.790K
YoY Change -532.88% 522.08%
% of Gross Profit -0.19% 0.28%
Operating Expenses $1.333M $1.280M
YoY Change -17.08% -23.21%
Operating Profit $336.0K $418.1K
YoY Change -366.79% 744.46%
Interest Expense -$36.91K $76.76K
YoY Change -66.41% 442.21%
% of Operating Profit -10.98% 18.36%
Other Income/Expense, Net
YoY Change
Pretax Income $299.1K $341.3K
YoY Change -226.83% 865.52%
Income Tax $14.48K
% Of Pretax Income 4.84%
Net Earnings $284.6K $341.3K
YoY Change -220.69% 865.49%
Net Earnings / Revenue 4.8% 5.93%
Basic Earnings Per Share $0.15
Diluted Earnings Per Share $0.12 $0.15
COMMON SHARES
Basic Shares Outstanding 2.313M 2.313M
Diluted Shares Outstanding 2.313M

Balance Sheet

Concept 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $151.5K $200.2K
YoY Change -65.47% -48.31%
Cash & Equivalents $151.5K $200.2K
Short-Term Investments
Other Short-Term Assets $165.4K $313.3K
YoY Change -31.47% 54.58%
Inventory $4.064M $4.438M
Prepaid Expenses $165.4K $313.3K
Receivables $414.7K $585.3K
Other Receivables $3.250M $3.406M
Total Short-Term Assets $8.045M $8.942M
YoY Change -26.85% -10.17%
LONG-TERM ASSETS
Property, Plant & Equipment $318.6K $358.4K
YoY Change -33.29% 564.66%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $4.000K
YoY Change -100.0% 0.0%
Total Long-Term Assets $354.4K $399.3K
YoY Change -32.09% 302.16%
TOTAL ASSETS
Total Short-Term Assets $8.045M $8.942M
Total Long-Term Assets $354.4K $399.3K
Total Assets $8.400M $9.342M
YoY Change -27.09% -7.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $948.5K $625.3K
YoY Change -39.68% 41.13%
Accrued Expenses $461.2K $343.2K
YoY Change -38.62% 16.29%
Deferred Revenue
YoY Change
Short-Term Debt $1.459M $2.653M
YoY Change -54.94% -22.86%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.869M $4.057M
YoY Change -56.18% -21.66%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $172.1K $210.1K
YoY Change -48.7%
Total Long-Term Liabilities $172.1K $210.1K
YoY Change -48.7%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.869M $4.057M
Total Long-Term Liabilities $172.1K $210.1K
Total Liabilities $3.041M $4.268M
YoY Change -55.82% -17.61%
SHAREHOLDERS EQUITY
Retained Earnings -$7.550M -$7.835M
YoY Change -8.71% -2.49%
Common Stock $12.91M $12.91M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.359M $5.074M
YoY Change
Total Liabilities & Shareholders Equity $8.400M $9.342M
YoY Change -27.09% -7.08%

Cashflow Statement

Concept 2023 Q1 2022 Q4
OPERATING ACTIVITIES
Net Income $284.6K $341.3K
YoY Change -220.69% 865.49%
Depreciation, Depletion And Amortization -$3.160K $4.790K
YoY Change -532.88% 522.08%
Cash From Operating Activities $1.145M $726.1K
YoY Change 354.49% 164.36%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.193M -704.8K
YoY Change 495.62% 1158.4%
NET CHANGE
Cash From Operating Activities 1.145M 726.1K
Cash From Investing Activities
Cash From Financing Activities -1.193M -704.8K
Net Change In Cash -48.66K 21.28K
YoY Change -194.47% -90.27%
FREE CASH FLOW
Cash From Operating Activities $1.145M $726.1K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
200155
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
438735
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
585268
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1290481
CY2022Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
222991
CY2022Q4 uuu Receivables From Employees
ReceivablesFromEmployees
9330
CY2022Q1 uuu Receivables From Employees
ReceivablesFromEmployees
6731
CY2022Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
817589
CY2022Q1 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
1297212
CY2022Q4 uuu Due From Factor
DueFromFactor
3173826
CY2022Q1 uuu Due From Factor
DueFromFactor
2792901
CY2022Q4 us-gaap Inventory Net
InventoryNet
4437580
CY2022Q1 us-gaap Inventory Net
InventoryNet
6229061
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
313277
CY2022Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
241342
CY2022Q4 us-gaap Assets Current
AssetsCurrent
8942427
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
106266
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
160025
CY2022Q4 uuu Commissions And Other
CommissionsAndOther
87517
CY2022Q1 uuu Commissions And Other
CommissionsAndOther
459440
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4057384
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
6547304
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
210139
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
335411
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2312887
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2312887
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
4638406
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-106138
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
4532268
CY2022Q1 us-gaap Assets Current
AssetsCurrent
10999251
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
36891
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
40243
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
358387
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
477627
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4000
CY2022Q4 us-gaap Assets
Assets
9341705
CY2022Q1 us-gaap Assets
Assets
11521121
CY2022Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2471236
CY2022Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2157086
CY2022Q4 us-gaap Notes Payable To Bank Current
NotesPayableToBankCurrent
181440
CY2022Q1 us-gaap Notes Payable To Bank Current
NotesPayableToBankCurrent
1081440
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
149408
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
131880
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
625270
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1572356
CY2022Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
436247
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2312887
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2312887
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
23129
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
23129
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
12885841
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
12885841
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7834788
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8270564
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
5074182
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
4638406
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9341705
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2312887
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2312887
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2312887
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2312887
dei Entity Registrant Name
EntityRegistrantName
UNIVERSAL SECURITY INSTRUMENTS INC
dei Entity Central Index Key
EntityCentralIndexKey
0000102109
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2312887
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2312887
uuu Accounts Receivables Factoring Agreement Term
AccountsReceivablesFactoringAgreementTerm
P2Y
CY2022Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-31747
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-0898545
dei Entity Address Address Line1
EntityAddressAddressLine1
11407 Cronhill Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite A
dei Entity Address City Or Town
EntityAddressCityOrTown
Owings Mills
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11521121
CY2022Q4 us-gaap Revenues
Revenues
5758661
CY2021Q4 us-gaap Revenues
Revenues
5319014
CY2022Q4 uuu Cost Of Goods Sold Other
CostOfGoodsSoldOther
4060422
CY2021Q4 uuu Cost Of Goods Sold Other
CostOfGoodsSoldOther
3602391
CY2022Q4 us-gaap Gross Profit
GrossProfit
1698239
CY2021Q4 us-gaap Gross Profit
GrossProfit
1716623
CY2022Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1178502
CY2021Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1569746
CY2022Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
101670
CY2021Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
97370
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
418067
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
49507
CY2022Q4 us-gaap Interest Expense
InterestExpense
76755
CY2021Q4 us-gaap Interest Expense
InterestExpense
14156
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
341312
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
35351
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2312887
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2312887
us-gaap Revenues
Revenues
16251106
us-gaap Revenues
Revenues
15259235
uuu Cost Of Goods Sold Other
CostOfGoodsSoldOther
11570029
uuu Cost Of Goods Sold Other
CostOfGoodsSoldOther
10708109
us-gaap Gross Profit
GrossProfit
4681077
us-gaap Gross Profit
GrossProfit
4551126
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3750348
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4059988
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
200602
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
4732870
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
341312
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
5074182
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
4716556
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
14641
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
4731197
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
107696
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
4838893
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
35351
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
4874244
us-gaap Net Income Loss
NetIncomeLoss
435776
us-gaap Net Income Loss
NetIncomeLoss
157688
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14846
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6955
uuu Increase Decrease In Accounts Receivable And Due From Factor
IncreaseDecreaseInAccountsReceivableAndDueFromFactor
-98698
uuu Increase Decrease In Accounts Receivable And Due From Factor
IncreaseDecreaseInAccountsReceivableAndDueFromFactor
1657549
uuu Decrease Increase In Inventories Prepaid Expenses And Other
DecreaseIncreaseInInventoriesPrepaidExpensesAndOther
-1719546
uuu Decrease Increase In Inventories Prepaid Expenses And Other
DecreaseIncreaseInInventoriesPrepaidExpensesAndOther
808245
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1921596
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
189243
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
347270
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2111908
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
314150
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
2338527
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
900000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-585850
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2338527
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-238580
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
226619
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
438735
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
160604
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
200155
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
387223
us-gaap Interest Paid Net
InterestPaidNet
200776
us-gaap Interest Paid Net
InterestPaidNet
37954
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
157000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
359547
CY2022Q1 uuu Operating Lease Liabilities Current
OperatingLeaseLiabilitiesCurrent
149408
CY2022Q1 uuu Operating Lease Liabilities Noncurrent
OperatingLeaseLiabilitiesNoncurrent
210139
dei Entity Address Country
EntityAddressCountry
MD
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
21117
dei City Area Code
CityAreaCode
410
dei Local Phone Number
LocalPhoneNumber
363-3000
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
UUU
dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2312887
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
294177
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
295496
us-gaap Operating Income Loss
OperatingIncomeLoss
636552
us-gaap Operating Income Loss
OperatingIncomeLoss
195642
CY2022Q1 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
985077
us-gaap Interest Expense
InterestExpense
200776
us-gaap Interest Expense
InterestExpense
37954
us-gaap Net Income Loss
NetIncomeLoss
435776
us-gaap Net Income Loss
NetIncomeLoss
157688
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2022Q4 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
0
CY2022Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
817589
CY2022Q4 uuu Accounts Receivable
AccountsReceivable
725000
CY2022Q4 uuu Refunds Of Customs Payments Including Interest Requested
RefundsOfCustomsPaymentsIncludingInterestRequested
300000
CY2015 uuu Percentage Of Line Of Credit Facility Maximum Borrowing Capacity Of Eligible Accounts Receivable
PercentageOfLineOfCreditFacilityMaximumBorrowingCapacityOfEligibleAccountsReceivable
0.80
CY2015 uuu Percentage Of Over Advance Of Line Of Credit Facility Maximum Borrowing Capacity Of Eligible Accounts Receivable
PercentageOfOverAdvanceOfLineOfCreditFacilityMaximumBorrowingCapacityOfEligibleAccountsReceivable
1
CY2015 uuu Maximum Percentage Of Over Advance Of Line Of Credit Facility Maximum Borrowing Capacity Of Eligible Accounts Receivable
MaximumPercentageOfOverAdvanceOfLineOfCreditFacilityMaximumBorrowingCapacityOfEligibleAccountsReceivable
0.50
CY2015Q1 us-gaap Line Of Credit Facility Capacity Available For Trade Purchases
LineOfCreditFacilityCapacityAvailableForTradePurchases
500000
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
2471000
us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.02
CY2022Q4 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0950
CY2022Q4 us-gaap Revenues
Revenues
5758661
CY2021Q4 us-gaap Revenues
Revenues
5319014
us-gaap Revenues
Revenues
16251106
us-gaap Revenues
Revenues
15259235
CY2022Q4 uuu Purchase Of Inventory And Other Company
PurchaseOfInventoryAndOtherCompany
523000
uuu Purchase Of Inventory And Other Company
PurchaseOfInventoryAndOtherCompany
1513000
CY2021Q4 uuu Purchase Of Inventory And Other Company
PurchaseOfInventoryAndOtherCompany
509000
uuu Purchase Of Inventory And Other Company
PurchaseOfInventoryAndOtherCompany
1332000
uuu Maximum Amount Outstanding
MaximumAmountOutstanding
217066
uuu Maximum Amount Outstanding
MaximumAmountOutstanding
210773
CY2022Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
0
uuu Allowance Related To Amounts Due From Factor
AllowanceRelatedToAmountsDueFromFactor
0
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
157000
uuu Number Of Potentially Dilutive Common Stock Equivalents
NumberOfPotentiallyDilutiveCommonStockEquivalents
0
uuu Number Of Potentially Dilutive Common Stock Equivalents
NumberOfPotentiallyDilutiveCommonStockEquivalents
0
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
100000
CY2022Q4 us-gaap Notes Payable To Bank Current
NotesPayableToBankCurrent
181440
us-gaap Operating Lease Expense
OperatingLeaseExpense
14500
uuu Operating Lease Rent Increment Percentage
OperatingLeaseRentIncrementPercentage
0.030
us-gaap Lease Practical Expedients Package
LeasePracticalExpedientsPackage
true
uuu Non Cash Right Of Use Asset In Exchange For Operating Lease Liability
NonCashRightOfUseAssetInExchangeForOperatingLeaseLiability
485000
uuu Adoption Of Lease Expenses Increased
AdoptionOfLeaseExpensesIncreased
468000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
350468
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
359547
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y3M
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.055
us-gaap Operating Lease Payments
OperatingLeasePayments
113513
us-gaap Operating Lease Cost
OperatingLeaseCost
114617
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
25226
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
155512
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
160179
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
26760
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
367677
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
8130

Files In Submission

Name View Source Status
0001410578-23-000138-index-headers.html Edgar Link pending
0001410578-23-000138-index.html Edgar Link pending
0001410578-23-000138.txt Edgar Link pending
0001410578-23-000138-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
uuu-20221231.xsd Edgar Link pending
uuu-20221231x10q.htm Edgar Link pending
uuu-20221231xex31d1.htm Edgar Link pending
uuu-20221231xex31d2.htm Edgar Link pending
uuu-20221231xex32d1.htm Edgar Link pending
uuu-20221231xex99d1.htm Edgar Link pending
uuu-20221231xex99d1001.jpg Edgar Link pending
uuu-20221231xex99d1002.jpg Edgar Link pending
uuu-20221231_cal.xml Edgar Link unprocessable
uuu-20221231_def.xml Edgar Link unprocessable
uuu-20221231_pre.xml Edgar Link unprocessable
uuu-20221231_lab.xml Edgar Link unprocessable
uuu-20221231x10q_htm.xml Edgar Link completed